This Article Full Text Full Text (PDF) All Versions of this Article: 44/4/394    most recent 01.HYP.0000141413.91223.2cv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bianchi, G. Articles by Manunta, P. Search for Related Content PubMed PubMed Citation Articles by Bianchi, G. Articles by Manunta, P. Related Collections Clinical genetics Other hypertension

(Hypertension. 2004;44:394.)
© 2004 American Heart Association, Inc.

Editorial Commentary

Adducin, Renal Intermediate Phenotypes, and Hypertension

From the Chair and School of Nephrology, University Vita Salute San Raffaele, Division of Nephrology, San Raffaele Hospital, Milan, Italy.

Correspondence to Giuseppe Bianchi, MD, Chair and School of Nephrology, University Vita Salute San Raffaele, Division of Nephrology, Dialysis and Hypertension, IRCCS San Raffaele Hospital, Via Olgettina, 60, 20132 Milan, Italy. E-mail bianchi.giuseppe@hsr.it

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Genetics of hypertension with its disappointing results may evoke reactions ranging from enthusiasm and hope to suspicion and skepticism. A variety of reasons may account for these contrasting results¹ that cannot be discussed here. However, in our opinion, 2 of these reasons are the most important ones: First, there is clear contradiction between the well established notion of the enormous heterogeneity of hypertension (in terms of molecular, biological, and clinical mechanisms) and the demand that a gene variant must be active across different populations, race, age, gender, etc. Second, the probability models of frequentist statistics, based on randomness, trivialize the ordered complexity of biological systems based on natural laws.² In fact, all the available statistical genetic guidelines for defining causation of a single gene in a complex disease, like hypertension, are unable to fully account for genetic or environmental interactions.³

More than 50 years of pathophysiological, clinical, and epidemiological studies have clearly shown that these interactions are of paramount importance for the elevation of blood pressure. In fact, it is highly unlikely that the same molecular mechanism may account for a disease that affects up to 40% of the adult population of the industrialized countries. Interactions among these factor varieties can only be inferred from empirical observations and not from deductive mathematical logic.^3,4

Along this line, studies trying to correlate genotypes with intermediate phenotypes, that are along biologically plausible pathways linking the genes of interest to blood pressure, may reduce this complexity and, therefore, provide more consistent data across the . . . [Full Text of this Article]

This article has been cited by other articles:

				K. Skov, J. K. Madsen, H. E. Hansen, L. Zagato, E. Frandsen, G. Bianchi, and M. J. Mulvany Renal Haemodynamics are not Related to Genotypes in Offspring of Parents with Essential Hypertension Journal of Renin-Angiotensin-Aldosterone System, March 1, 2006; 7(1): 47 - 55. [Abstract] [PDF]

				G. Bianchi, P. Ferrari, and J. A. Staessen Adducin Polymorphism: Detection and Impact on Hypertension and Related Disorders Hypertension, March 1, 2005; 45(3): 331 - 340. [Abstract] [Full Text] [PDF]